Clinical Trial Update: Intranasal Dexmedetomidine Sedation During Intra-articular Joint Injections in Pediatric Population [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating intranasal dexmedetomidine for sedation during intra-articular joint injections in children with juvenile idiopathic arthritis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Joint Inflammation
• Juvenile Idiopathic Arthritis

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: University of Oulu | Conditions: Juvenile Idiopathic Arthritis, Joint Inflammation | Phase 4 | Status: COMPLETED